https://scholars.lib.ntu.edu.tw/handle/123456789/620217
標題: | Phase I/Ib clinical trial of sabatolimab, an anti–TIM-3 antibody, alone and in combination with spartalizumab, an anti–PD-1 antibody, in advanced solid tumors | 作者: | Curigliano G. Gelderblom H. Mach N. Doi T. Tai D. Forde P.M. Sarantopoulos J. Bedard P.L. CHIA-CHI LIN Stephen Hodi F. Wilgenhof S. Santoro A. Sabatos-Peyton C.A. Longmire T.A. Xyrafas A. Sun H. Gutzwiller S. Manenti L. Naing A. |
公開日期: | 2021 | 出版社: | American Association for Cancer Research Inc. | 卷: | 27 | 期: | 13 | 起(迄)頁: | 3620-3629 | 來源出版物: | Clinical Cancer Research | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85109174113&doi=10.1158%2f1078-0432.CCR-20-4746&partnerID=40&md5=dc5d02c7e0dacbda2ecde2d2484180bb https://scholars.lib.ntu.edu.tw/handle/123456789/620217 |
ISSN: | 1078-0432 | DOI: | 10.1158/1078-0432.CCR-20-4746 |
顯示於: | 臨床醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。